Search results
Research explains new method to engineer immune cells that could treat multiple cancer patients
Medical Xpress· 6 hours agoThis novel technology, described in a study published in Nature Biotechnology, marks a major step toward enabling the mass production of cell therapies like CAR-T
WATT Fuel Cell's Advanced Manufacturing Plant Expands Capacity and Capabilities as the Company...
WTRF Wheeling· 9 hours agoWATT Fuel Cell expands its U.S. additive manufacturing capabilities and footprint at its Mount...
NYC pols seek social workers in all NYPD precincts
amNewYork· 2 hours agoGetting arrested in NYC entails getting cuffed, fingerprinted, placed in a holding cell — and, soon, consulting with a social worker, should a new City...
Customized production of antiviral coatings and cell culture surfaces
Phys.org· 2 hours agoThe results have been published in the journal Advanced Materials Interfaces and applied in a first...
Assassin Gene Discovery Shifts Cancer Treatment Paradigms – “Very Unexpected Finding”
SciTechDaily· 4 hours agoScientists have discovered that the way cancer cells die from chemotherapy appears to be different...
How can understanding misfolded proteins help improve disease treatments?
Phys.org· 2 hours agoProteins are like tiny machines in our bodies, helping with almost everything we do, including...
Cell Signaling planning needs to start over
Gloucester Daily Times· 12 hours agoMANCHESTER-BY-THE-SEA — The recent death of Planning Board Chair Ronald Mastrogiacomo and the illness of another board member have pushed back...
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 2 hours agoThe Food and Drug Administration on Thursday approved Amgen's therapy for patients with the most...
The Cost of Competing With China
New York Times· 3 hours agoThe Biden administration is betting that new China tariffs will be politically popular, even if they could slow the transition from fossil fuels....
US FDA approves Amgen drug for small cell lung cancer
AOL· 2 hours agoThe therapy, marketed under the name Imdelltra, is part of Amgen's pipeline of bispecific antibodies, which are designed to attach to a cancer cell and an immune ...
